TORPEDO: Prospective, double blind, randomized clinical trial comparing the use of Ketorolac verse placebo during live donor nephrectomy for kidney transplant
Transplantation Reports · 2017
DOI: 10.1016/j.tpr.2017.05.002 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Transplantation Reports, 2017. Verfasst von Jeffrey Campsen und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Center for Research Resources, National Center for Advancing Translational Sciences, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Center for Research Resources
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Campsen, J., Call, T., Thiesset, H. F., Rosales, A., & Kim, R. D. (2017). TORPEDO: Prospective, double blind, randomized clinical trial comparing the use of Ketorolac verse placebo during live donor nephrectomy for kidney transplant. Transplantation Reports. https://doi.org/10.1016/j.tpr.2017.05.002
Vancouver
Campsen J, Call T, Thiesset HF, Rosales A, Kim RD. TORPEDO: Prospective, double blind, randomized clinical trial comparing the use of Ketorolac verse placebo during live donor nephrectomy for kidney transplant. Transplantation Reports. 2017. doi:10.1016/j.tpr.2017.05.002
BibTeX
@article{Campsen2017,
author = {Campsen, Jeffrey and Call, Tyler and Thiesset, Heather F. and Rosales, Alec and Kim, Robin D.},
title = {TORPEDO: Prospective, double blind, randomized clinical trial comparing the use of Ketorolac verse placebo during live donor nephrectomy for kidney transplant},
journal = {Transplantation Reports},
year = {2017},
doi = {10.1016/j.tpr.2017.05.002}
}
EUVIMED